Company Overview of Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc., a biotech company, engages in the discovery and development of peptide therapeutics for the treatment of psychiatric disorders. The company was incorporated in 2007 and is based in San Diego, California. Psylin Neurosciences, Inc. is a joint venture between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc.
9360 Towne Center Drive
San Diego, CA 92121
Founded in 2007
Key Executives for Psylin Neurosciences, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Psylin Neurosciences, Inc., please visit www.psylin.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.